tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN
Holding SLN?
Track your performance easily

Silence Therapeutics (SLN) Ownership - Who Owns Silence Therapeutics?

126 Followers

Silence Therapeutics (SLN) Ownership Overview

6.10%1.45%47.22%0.19%45.03%
6.10%
Insiders
47.22% Other Institutional Investors
0.19% ETFs
45.03% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 48.87% of the company’s stock is owned by Institutional Investors, 6.10% is owned by Insiders, and 45.03% is owned by Public Companies and Individual Investors.
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 48.67% of the company’s stock is owned by Institutional Investors, 6.10% is owned by Insiders, and 0.19% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$7397496

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,495,310Insider6.10%67,282,855
640,000Institution1.37%5,068,800
406,903Institution0.87%3,222,672
387,400Institution0.83%3,068,208
76,769Institution0.16%608,010
29,417Institution0.06%232,983
8,077Institution0.02%63,970
4,796Institution0.01%37,984
4,238Institution<0.01%33,565
3,200Institution<0.01%25,344

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
640,000Institution1.37%5,068,800
29,417Institution0.06%232,983
4,238Institution<0.01%33,565
3,200Institution<0.01%25,344

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
76,769Institution0.16%588,818
8,077Institution0.02%61,951
4,796Institution0.01%37,984

FAQ

Who Owns Silence Therapeutics (SLN)?
According to the latest TipRanks data, approximately 47.22% of the company's stock is held by institutional investors, 6.10% is held by insiders, and 45.03% is held by retail investors.
    What percentage of Silence Therapeutics (SLN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 47.22% of Silence Therapeutics (SLN) stock is held by institutional investors.
      What percentage of Silence Therapeutics (SLN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 45.03% of Silence Therapeutics (SLN) stock is held by retail investors.
        Who owns the most shares of Silence Therapeutics (SLN)?
        Raymond Debbane owns the most shares of Silence Therapeutics (SLN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis